Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda J Craig

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cell Reports. Medicine|January 27, 2024
Lineage and ecology define liver tumor evolution in response to treatmentMahler Revsine, Limin Wang, Marshonna Forgues, et al.
Hepatology (Baltimore, Md.)|November 25, 2020
DNA Methylation Profiling of Human HepatocarcinogenesisGabriela Hernandez-Meza, Johann von Felden, Edgar E Gonzalez-Kozlova, et al.
Molecular Cancer Therapeutics|June 20, 2019
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Amanda J Craig, Mary E Duffy, et al.
Oncogene|October 24, 2020
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinomaJohann von Felden, Amanda J Craig, Teresa Garcia-Lezana, et al.
Journal of Hepatology|March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer developmentLuana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Oncogene|April 10, 2018
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinomaIsmail Labgaa, Carlos Villacorta-Martin, Delia D'Avola, et al.
Journal of Hepatology|April 4, 2022
Metformin treatment rescues CD8<sup>+</sup> T-cell response to immune checkpoint inhibitor therapy in mice with NAFLDSimon Wabitsch, Justin D McCallen, Olena Kamenyeva, et al.
Plos Genetics|June 24, 2021
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinomaAmanda J Craig, Teresa Garcia-Lezana, Marina Ruiz de Galarreta, et al.
Cell Reports|November 19, 2023
Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencingAmanda J Craig, Maruhen A Datsch Silveira, Lichun Ma, et al.
Nature Communications|January 17, 2020
Intratumoral heterogeneity and clonal evolution in liver cancerBojan Losic, Amanda J Craig, Carlos Villacorta-Martin, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cell Reports. Medicine|January 27, 2024
Lineage and ecology define liver tumor evolution in response to treatmentMahler Revsine, Limin Wang, Marshonna Forgues, et al.
Hepatology (Baltimore, Md.)|November 25, 2020
DNA Methylation Profiling of Human HepatocarcinogenesisGabriela Hernandez-Meza, Johann von Felden, Edgar E Gonzalez-Kozlova, et al.
Molecular Cancer Therapeutics|June 20, 2019
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Amanda J Craig, Mary E Duffy, et al.
Oncogene|October 24, 2020
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinomaJohann von Felden, Amanda J Craig, Teresa Garcia-Lezana, et al.
Journal of Hepatology|March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer developmentLuana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Oncogene|April 10, 2018
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinomaIsmail Labgaa, Carlos Villacorta-Martin, Delia D'Avola, et al.
Journal of Hepatology|April 4, 2022
Metformin treatment rescues CD8<sup>+</sup> T-cell response to immune checkpoint inhibitor therapy in mice with NAFLDSimon Wabitsch, Justin D McCallen, Olena Kamenyeva, et al.
Plos Genetics|June 24, 2021
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinomaAmanda J Craig, Teresa Garcia-Lezana, Marina Ruiz de Galarreta, et al.
Cell Reports|November 19, 2023
Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencingAmanda J Craig, Maruhen A Datsch Silveira, Lichun Ma, et al.
Nature Communications|January 17, 2020
Intratumoral heterogeneity and clonal evolution in liver cancerBojan Losic, Amanda J Craig, Carlos Villacorta-Martin, et al.
Pageof 3